![David Nelles](https://cdn.zonebourse.com/static/resize/768/576//static/images/insiders/unknown.png)
David Nelles
Algemeen Directeur bij U1 Bio, Inc.
Profiel
David Nelles was the founder and had held the position of Chief Technology Officer at Locanabio, Inc. from 2016 to 2020.
He is currently the Chief Executive Officer & Director at U1 Bio, Inc. which is his current job.
Dr. Nelles founded Locanabio, Inc. in 2016.
Actieve functies van David Nelles
Bedrijven | Functie | Begin |
---|---|---|
U1 Bio, Inc.
![]() U1 Bio, Inc. Miscellaneous Commercial ServicesCommercial Services U1 Bio, Inc. provides biotechnology research and development services. The CEO of the American company is David Nelles. | Algemeen Directeur | - |
Eerdere bekende functies van David Nelles
Bedrijven | Functie | Einde |
---|---|---|
Locanabio, Inc.
![]() Locanabio, Inc. Packaged SoftwareTechnology Services Locana, Inc. engages in the provision of ribonucleic acid targeting gene therapy. Its platform technology addresses a wide spectrum of human genetic diseases. It has advanced a powerful modular RNA targeting-effector approach to optimize and advance therapeutic candidates that is distinct from DNA-targeted approaches and nucleic acid-based RNA targeting. The company was founded by Gene Yeo and David Nelles in 2016 and is headquartered in San Diego, CA. | Oprichter | 01-01-2020 |
Ervaring
Beklede functies
Actief
Inactief
Beursgenoteerde bedrijven
Bedrijven in privébezit
Connecties
Eerstegraads connecties
Bedrijven verbonden in de eerste graad
Man
Vrouw
Besturend
Uitvoerend
Verwante bedrijven
Bedrijven in privébezit | 2 |
---|---|
Locanabio, Inc.
![]() Locanabio, Inc. Packaged SoftwareTechnology Services Locana, Inc. engages in the provision of ribonucleic acid targeting gene therapy. Its platform technology addresses a wide spectrum of human genetic diseases. It has advanced a powerful modular RNA targeting-effector approach to optimize and advance therapeutic candidates that is distinct from DNA-targeted approaches and nucleic acid-based RNA targeting. The company was founded by Gene Yeo and David Nelles in 2016 and is headquartered in San Diego, CA. | Technology Services |
U1 Bio, Inc.
![]() U1 Bio, Inc. Miscellaneous Commercial ServicesCommercial Services U1 Bio, Inc. provides biotechnology research and development services. The CEO of the American company is David Nelles. | Commercial Services |